{
    "nctId": "NCT01790399",
    "briefTitle": "IDENTIFICATION OF SENTINEL NODE(S) IN BREAST CANCER",
    "officialTitle": "IDENTIFICATION OF SENTINEL NODE(S) BY SENTIMAG\u00ae /SIENNA+ IN BREAST CANCER: FEASIBILITY STUDY",
    "overallStatus": "UNKNOWN",
    "conditions": "BREAST CANCER",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 115,
    "primaryOutcomeMeasure": "Sentinel node(s)detected with new technical",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient with invasive breast cancer or microinfiltrant proven by cytology and histo-or whatever the histological type\n* cT0/cT1/cT2 (up to 5 cm) CN0 clinical and / or ultrasound and without prior treatment (chemotherapy or neoadjuvant hormone )\n* Age greater than or equal to 18\n* Reporting of breast surgery and axillary staging of sentinel lymph node\n* Using effective contraception (BHCG negative)\n* Patient affiliated with a health insurance\n* Consent signed by the patient\n\nExclusion Criteria:\n\n* T3 or T4 tumors (\\> 5 cm, cutaneous or muscle inflammation or cancer)\n* Presence of a clinically suspicious axillary adenopathy or imaging\n* Tumors bifocal or multifocal known before Surgery\n* History of breast surgery or axillary\n* Patient metastatic\n* Patient with a cons-indication anesthesia and / or surgery\n* Intolerance or hypersensitivity to the compounds or iron dextran or superparamagnetic iron oxide or to Patent blue dye in centers where it is commonly used\n* Patient can not receive a radioactive isotope to the sentinel lymph node resection\n* Allergy radioactive product\n* Chronic iron overload\n* Pacemaker or other implantable device in the chest wall\n* Failure to submit to medical study for geographical, social or psychological\n* Patient deprived of liberty or under guardianship\n* Pregnant or lactating",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}